Loading…
Reported covered position: Chief of Staff, Leg Director, US House of Reps.
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Improving Transparency and Accuracy in Medicare Part D Spending Act
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
H.R. 1316, Prescription Drug Price Transparency Act; H.R. 1038, Improving Transparency and Accuracy in Medicare Part D Spending Act; S. 413, Improving Transparency and Accuracy in Medicare Part D Spending Act; H.R. 592, Pharmacy and Medically Underserved Areas Enhancement Act; S. 109, Pharmacy and Medically Underserved Areas Enhancement Act; H.R.1939 - To amend title XVIII of the Social Security Act to ensure equal access of Medicare beneficiaries to community pharmacies in underserved areas as network pharmacies under Medicare prescription drug coverage, and for other purposes
Improving Transparency and Accuracy in Medicare Part D Spending Act
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
NATIONAL COMMUNITY PHARMACISTS ASSOCIATION via NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
2017 · third_quarter · Q3
Unified Framework for Fixing Our Broken Tax Code; H.R. 631, Death Tax Repeal Act of 2017; S. 205, Death Tax Repeal Act of 2017
Supporting implementation of Sec. 745 of National Defense Authorization Act for Fiscal Year 2017; H.R. 2810 - National Defense Authorization Act for Fiscal Year 2018- Generic drug pricing transparency and TRICARE Pharmacy Benefits Provisions; S. 1519 National Defense Authorization Act for Fiscal Year 2018- Generic drug pricing transparency and TRICARE Pharmacy Benefits Provisions
Source: Senate LDA
H.R. 1316, Prescription Drug Price Transparency Act; H.R. 1038, Improving Transparency and Accuracy in Medicare Part D Spending Act; S. 413, Improving Transparency and Accuracy in Medicare Part D Spending Act; H.R. 592, Pharmacy and Medically Underserved Areas Enhancement Act; S. 109, Pharmacy and Medically Underserved Areas Enhancement Act; H.R.1939 - To amend title XVIII of the Social Security Act to ensure equal access of Medicare beneficiaries to community pharmacies in underserved areas as network pharmacies under Medicare prescription drug coverage, and for other purposes; S.637 Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017; HR 394/ S 85, Restoring Access to Medication Act; HR 3921/S 1827, KIDS Act of 2017; HR 3271, Protecting Access to Diabetes Supplies Act of 2017; S. 870, Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 Discussion draft, preventing cash price disclosure restrictions under Medicare prescription drug plan contracts with pharmacies
Improving Transparency and Accuracy in Medicare Part D Spending Act
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
H.R. 1316, Prescription Drug Price Transparency Act; H.R. 1038, Improving Transparency and Accuracy in Medicare Part D Spending Act; S. 413, Improving Transparency and Accuracy in Medicare Part D Spending Act; H.R. 592, Pharmacy and Medically Underserved Areas Enhancement Act; S. 109, Pharmacy and Medically Underserved Areas Enhancement Act; H.R.1939 - To amend title XVIII of the Social Security Act to ensure equal access of Medicare beneficiaries to community pharmacies in underserved areas as network pharmacies under Medicare prescription drug coverage, and for other purposes; S.637 Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017;
Affordable and Safe Prescription Drug Importation Act
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
S. 222, The Obama Care Replacement Act; S. 469, Affordable and Safe Prescription Drug Importation Act; H.R. 1245, Affordable and Safe Prescription Drug Importation Act; H.R. 1776, Improving Access to Affordable Prescription Drugs Act; S. 771, Improving Access to Affordable Prescription Drugs Act; H.R. 242, Medicare Prescription Drug Price Negotiation Act of 2017; S. 41, Medicare Prescription Drug Price Negotiation Act of 2017; Drug Pricing Transparency
Affordable and Safe Prescription Drug Importation Act
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
H.R. 1628, American Health Care Act; Issues related to legislation repealing and replacing the affordable care act; S. 637, Creating Transparency to Have Drug Rebates Unlocked (C-Thru) Act of 2017; S. 222, The Obama Care Replacement Act' S. 469, Affordable and Safe Prescription Drug Importation Act; H.R. 1245, Affordable and Safe Prescription Drug Importation Act; H.R. 1776, Improving Access to Affordable Prescription Drugs Act; S. 771, Improving Access to Affordable Prescription Drugs Act; H.R. 242, Medicare Prescription Drug Price Negotiation Act of 2017; S. 41, Medicare Prescription Drug Price Negotiation Act of 2017;
Affordable and Safe Prescription Drug Importation Act
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
S. 222, The Obama Care Replacement Act; S. 469, Affordable and Safe Prescription Drug Importation Act; H.R. 1245, Affordable and Safe Prescription Drug Importation Act; H.R. 1776, Improving Access to Affordable Prescription Drugs Act; S. 771, Improving Access to Affordable Prescription Drugs Act; H.R. 242, Medicare Prescription Drug Price Negotiation Act of 2017; S. 41, Medicare Prescription Drug Price Negotiation Act of 2017; Drug Pricing Transparency
DXM Abuse Prevention Act of 2017
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
Implementation of Public Law 114-198 pharmacy provisions; Implementation of Public Law 114-255 pharmacy provisions; H.R. 1854/S. 778, Prescription Drug Monitoring Act of 2017; S 892, Opioid Addiction Prevention Act of 2017; HR 3528, Every Prescription Conveyed Securely Act; H.R. 3545, Overdose Prevention and Patient Safety Act; S. 1850, Protecting Jessica Grubbs Legacy Act; H.R. 1271, DXM Abuse Prevention Act of 2017; H.R. 1375, Prescriber Support Act of 2017; S. 523, Budgeting for Opioid Addiction Treatment Act; S. 581, Jessies Law; S 1079, Protecting Americans from Dangerous Opioids Act;
Prescription Drug Price Transparency Act
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
H.R. 1316, Prescription Drug Price Transparency Act; H.R. 1038, Improving Transparency and Accuracy in Medicare Part D Spending Act; S. 413, Improving Transparency and Accuracy in Medicare Part D Spending Act; H.R. 592, Pharmacy and Medically Underserved Areas Enhancement Act; S. 109, Pharmacy and Medically Underserved Areas Enhancement Act; H.R.1939 - To amend title XVIII of the Social Security Act to ensure equal access of Medicare beneficiaries to community pharmacies in underserved areas as network pharmacies under Medicare prescription drug coverage, and for other purposes; S.637 Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017; HR 394/ S 85, Restoring Access to Medication Act; HR 3921/S 1827, KIDS Act of 2017; HR 3271, Protecting Access to Diabetes Supplies Act of 2017; S. 870, Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 Discussion draft, preventing cash price disclosure restrictions under Medicare prescription drug plan contracts with pharmacies
Prescription Drug Price Transparency Act
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
H.R. 1316, Prescription Drug Price Transparency Act; H.R. 1038, Improving Transparency and Accuracy in Medicare Part D Spending Act; S. 413, Improving Transparency and Accuracy in Medicare Part D Spending Act; H.R. 592, Pharmacy and Medically Underserved Areas Enhancement Act; S. 109, Pharmacy and Medically Underserved Areas Enhancement Act; H.R.1939 - To amend title XVIII of the Social Security Act to ensure equal access of Medicare beneficiaries to community pharmacies in underserved areas as network pharmacies under Medicare prescription drug coverage, and for other purposes; S.637 Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017;
Prescription Drug Price Transparency Act
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
H.R. 1316, Prescription Drug Price Transparency Act; H.R. 1038, Improving Transparency and Accuracy in Medicare Part D Spending Act; S. 413, Improving Transparency and Accuracy in Medicare Part D Spending Act; H.R. 592, Pharmacy and Medically Underserved Areas Enhancement Act; S. 109, Pharmacy and Medically Underserved Areas Enhancement Act; H.R.1939 - To amend title XVIII of the Social Security Act to ensure equal access of Medicare beneficiaries to community pharmacies in underserved areas as network pharmacies under Medicare prescription drug coverage, and for other purposes
Prescriber Support Act of 2017
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
Implementation of Public Law 114-198 pharmacy provisions; Implementation of Public Law 114-255 pharmacy provisions; H.R. 1854/S. 778, Prescription Drug Monitoring Act of 2017; S 892, Opioid Addiction Prevention Act of 2017; HR 3528, Every Prescription Conveyed Securely Act; H.R. 3545, Overdose Prevention and Patient Safety Act; S. 1850, Protecting Jessica Grubbs Legacy Act; H.R. 1271, DXM Abuse Prevention Act of 2017; H.R. 1375, Prescriber Support Act of 2017; S. 523, Budgeting for Opioid Addiction Treatment Act; S. 581, Jessies Law; S 1079, Protecting Americans from Dangerous Opioids Act;
American Health Care Act of 2017
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
H.R. 1628, American Health Care Act; Issues related to legislation repealing and replacing the affordable care act; S. 637, Creating Transparency to Have Drug Rebates Unlocked (C-Thru) Act of 2017; S. 222, The Obama Care Replacement Act' S. 469, Affordable and Safe Prescription Drug Importation Act; H.R. 1245, Affordable and Safe Prescription Drug Importation Act; H.R. 1776, Improving Access to Affordable Prescription Drugs Act; S. 771, Improving Access to Affordable Prescription Drugs Act; H.R. 242, Medicare Prescription Drug Price Negotiation Act of 2017; S. 41, Medicare Prescription Drug Price Negotiation Act of 2017;
American Health Care Act of 2017
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act; Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, specifically FDA funding for implementation of the Drug Quality and Security Act.; H.R. 1628, American Health Care Act of 2017; Better Care Reconciliation Act; H.R. 2430 the FDA Reauthorization Act (FDARA) of 2017; S.934 FDA Reauthorization Act of 2017;
American Health Care Act of 2017
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act; H.amdt. 278, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, specifically FDA funding for implementation of the Drug Quality and Security Act.; H.R. 1628, American Health Care Act of 2017; Better Care Reconciliation Act; H.R. 2430 the FDA Reauthorization Act (FDARA) of 2017; S.934 FDA Reauthorization Act of 2017;
Improving Access To Affordable Prescription Drugs Act
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
H.R. 1628, American Health Care Act; Issues related to legislation repealing and replacing the affordable care act; S. 637, Creating Transparency to Have Drug Rebates Unlocked (C-Thru) Act of 2017; S. 222, The Obama Care Replacement Act' S. 469, Affordable and Safe Prescription Drug Importation Act; H.R. 1245, Affordable and Safe Prescription Drug Importation Act; H.R. 1776, Improving Access to Affordable Prescription Drugs Act; S. 771, Improving Access to Affordable Prescription Drugs Act; H.R. 242, Medicare Prescription Drug Price Negotiation Act of 2017; S. 41, Medicare Prescription Drug Price Negotiation Act of 2017;
Improving Access To Affordable Prescription Drugs Act
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
S. 222, The Obama Care Replacement Act; S. 469, Affordable and Safe Prescription Drug Importation Act; H.R. 1245, Affordable and Safe Prescription Drug Importation Act; H.R. 1776, Improving Access to Affordable Prescription Drugs Act; S. 771, Improving Access to Affordable Prescription Drugs Act; H.R. 242, Medicare Prescription Drug Price Negotiation Act of 2017; S. 41, Medicare Prescription Drug Price Negotiation Act of 2017; Drug Pricing Transparency
Improving Access To Affordable Prescription Drugs Act
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
S. 222, The Obama Care Replacement Act; S. 469, Affordable and Safe Prescription Drug Importation Act; H.R. 1245, Affordable and Safe Prescription Drug Importation Act; H.R. 1776, Improving Access to Affordable Prescription Drugs Act; S. 771, Improving Access to Affordable Prescription Drugs Act; H.R. 242, Medicare Prescription Drug Price Negotiation Act of 2017; S. 41, Medicare Prescription Drug Price Negotiation Act of 2017; Drug Pricing Transparency
Prescription Drug Monitoring Act of 2017
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
Implementation of Public Law 114-198 pharmacy provisions; Implementation of Public Law 114-255 pharmacy provisions; H.R. 1854/S. 778, Prescription Drug Monitoring Act of 2017; S 892, Opioid Addiction Prevention Act of 2017; HR 3528, Every Prescription Conveyed Securely Act; H.R. 3545, Overdose Prevention and Patient Safety Act; S. 1850, Protecting Jessica Grubbs Legacy Act; H.R. 1271, DXM Abuse Prevention Act of 2017; H.R. 1375, Prescriber Support Act of 2017; S. 523, Budgeting for Opioid Addiction Treatment Act; S. 581, Jessies Law; S 1079, Protecting Americans from Dangerous Opioids Act;
Ensuring Seniors Access to Local Pharmacies Act of 2017
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
H.R. 1316, Prescription Drug Price Transparency Act; H.R. 1038, Improving Transparency and Accuracy in Medicare Part D Spending Act; S. 413, Improving Transparency and Accuracy in Medicare Part D Spending Act; H.R. 592, Pharmacy and Medically Underserved Areas Enhancement Act; S. 109, Pharmacy and Medically Underserved Areas Enhancement Act; H.R.1939 - To amend title XVIII of the Social Security Act to ensure equal access of Medicare beneficiaries to community pharmacies in underserved areas as network pharmacies under Medicare prescription drug coverage, and for other purposes; S.637 Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017; HR 394/ S 85, Restoring Access to Medication Act; HR 3921/S 1827, KIDS Act of 2017; HR 3271, Protecting Access to Diabetes Supplies Act of 2017; S. 870, Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 Discussion draft, preventing cash price disclosure restrictions under Medicare prescription drug plan contracts with pharmacies
Ensuring Seniors Access to Local Pharmacies Act of 2017
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
H.R. 1316, Prescription Drug Price Transparency Act; H.R. 1038, Improving Transparency and Accuracy in Medicare Part D Spending Act; S. 413, Improving Transparency and Accuracy in Medicare Part D Spending Act; H.R. 592, Pharmacy and Medically Underserved Areas Enhancement Act; S. 109, Pharmacy and Medically Underserved Areas Enhancement Act; H.R.1939 - To amend title XVIII of the Social Security Act to ensure equal access of Medicare beneficiaries to community pharmacies in underserved areas as network pharmacies under Medicare prescription drug coverage, and for other purposes; S.637 Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017;
Ensuring Seniors Access to Local Pharmacies Act of 2017
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
H.R. 1316, Prescription Drug Price Transparency Act; H.R. 1038, Improving Transparency and Accuracy in Medicare Part D Spending Act; S. 413, Improving Transparency and Accuracy in Medicare Part D Spending Act; H.R. 592, Pharmacy and Medically Underserved Areas Enhancement Act; S. 109, Pharmacy and Medically Underserved Areas Enhancement Act; H.R.1939 - To amend title XVIII of the Social Security Act to ensure equal access of Medicare beneficiaries to community pharmacies in underserved areas as network pharmacies under Medicare prescription drug coverage, and for other purposes
Medicare Prescription Drug Price Negotiation Act of 2017
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
S. 222, The Obama Care Replacement Act; S. 469, Affordable and Safe Prescription Drug Importation Act; H.R. 1245, Affordable and Safe Prescription Drug Importation Act; H.R. 1776, Improving Access to Affordable Prescription Drugs Act; S. 771, Improving Access to Affordable Prescription Drugs Act; H.R. 242, Medicare Prescription Drug Price Negotiation Act of 2017; S. 41, Medicare Prescription Drug Price Negotiation Act of 2017; Drug Pricing Transparency
Medicare Prescription Drug Price Negotiation Act of 2017
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
H.R. 1628, American Health Care Act; Issues related to legislation repealing and replacing the affordable care act; S. 637, Creating Transparency to Have Drug Rebates Unlocked (C-Thru) Act of 2017; S. 222, The Obama Care Replacement Act' S. 469, Affordable and Safe Prescription Drug Importation Act; H.R. 1245, Affordable and Safe Prescription Drug Importation Act; H.R. 1776, Improving Access to Affordable Prescription Drugs Act; S. 771, Improving Access to Affordable Prescription Drugs Act; H.R. 242, Medicare Prescription Drug Price Negotiation Act of 2017; S. 41, Medicare Prescription Drug Price Negotiation Act of 2017;
Medicare Prescription Drug Price Negotiation Act of 2017
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
S. 222, The Obama Care Replacement Act; S. 469, Affordable and Safe Prescription Drug Importation Act; H.R. 1245, Affordable and Safe Prescription Drug Importation Act; H.R. 1776, Improving Access to Affordable Prescription Drugs Act; S. 771, Improving Access to Affordable Prescription Drugs Act; H.R. 242, Medicare Prescription Drug Price Negotiation Act of 2017; S. 41, Medicare Prescription Drug Price Negotiation Act of 2017; Drug Pricing Transparency
FDA Reauthorization Act of 2017
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act; H.amdt. 278, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, specifically FDA funding for implementation of the Drug Quality and Security Act.; H.R. 1628, American Health Care Act of 2017; Better Care Reconciliation Act; H.R. 2430 the FDA Reauthorization Act (FDARA) of 2017; S.934 FDA Reauthorization Act of 2017;
FDA Reauthorization Act of 2017
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act; Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, specifically FDA funding for implementation of the Drug Quality and Security Act.; H.R. 1628, American Health Care Act of 2017; Better Care Reconciliation Act; H.R. 2430 the FDA Reauthorization Act (FDARA) of 2017; S.934 FDA Reauthorization Act of 2017;
National Defense Authorization Act for Fiscal Year 2018
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
Supporting implementation of Sec. 745 of National Defense Authorization Act for Fiscal Year 2017; H.R. 2810 - National Defense Authorization Act for Fiscal Year 2018- Generic drug pricing transparency and TRICARE Pharmacy Benefits Provisions; S. 1519 National Defense Authorization Act for Fiscal Year 2018- Generic drug pricing transparency and TRICARE Pharmacy Benefits Provisions
National Defense Authorization Act for Fiscal Year 2018
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
Supporting implementation of Sec. 745 of National Defense Authorization Act for Fiscal Year 2017; H.R. 2810 - National Defense Authorization Act for Fiscal Year 2018- Generic drug pricing transparency and TRICARE Pharmacy Benefits Provisions; S. 1519 National Defense Authorization Act for Fiscal Year 2018- Generic drug pricing transparency and TRICARE Pharmacy Benefits Provisions
Preserving Patient Access to Compounded Medications Act of 2017
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
Congressional Oversight of 340 B Program; Issues related to FDA implementation of The Drug Quality and Security Act related to the regulations of pharmacy compounding; Biosimilar naming; H.R. 421 Allowing Greater Access to Safe and Effective Contraception Act; H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017
Preserving Patient Access to Compounded Medications Act of 2017
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
Congressional Oversight of 340 B Program; Issues related to FDA implementation of The Drug Quality and Security Act related to the regulations of pharmacy compounding; Biosimilar naming; H.R. 421 Allowing Greater Access to Safe and Effective Contraception Act; H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017; HR 749, Lower Drug Costs through Competition Act
Protecting Access to Diabetes Supplies Act of 2017
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
H.R. 1316, Prescription Drug Price Transparency Act; H.R. 1038, Improving Transparency and Accuracy in Medicare Part D Spending Act; S. 413, Improving Transparency and Accuracy in Medicare Part D Spending Act; H.R. 592, Pharmacy and Medically Underserved Areas Enhancement Act; S. 109, Pharmacy and Medically Underserved Areas Enhancement Act; H.R.1939 - To amend title XVIII of the Social Security Act to ensure equal access of Medicare beneficiaries to community pharmacies in underserved areas as network pharmacies under Medicare prescription drug coverage, and for other purposes; S.637 Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017; HR 394/ S 85, Restoring Access to Medication Act; HR 3921/S 1827, KIDS Act of 2017; HR 3271, Protecting Access to Diabetes Supplies Act of 2017; S. 870, Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 Discussion draft, preventing cash price disclosure restrictions under Medicare prescription drug plan contracts with pharmacies
Every Prescription Conveyed Securely Act
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
Implementation of Public Law 114-198 pharmacy provisions; Implementation of Public Law 114-255 pharmacy provisions; H.R. 1854/S. 778, Prescription Drug Monitoring Act of 2017; S 892, Opioid Addiction Prevention Act of 2017; HR 3528, Every Prescription Conveyed Securely Act; H.R. 3545, Overdose Prevention and Patient Safety Act; S. 1850, Protecting Jessica Grubbs Legacy Act; H.R. 1271, DXM Abuse Prevention Act of 2017; H.R. 1375, Prescriber Support Act of 2017; S. 523, Budgeting for Opioid Addiction Treatment Act; S. 581, Jessies Law; S 1079, Protecting Americans from Dangerous Opioids Act;
Overdose Prevention and Patient Safety Act
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
Implementation of Public Law 114-198 pharmacy provisions; Implementation of Public Law 114-255 pharmacy provisions; H.R. 1854/S. 778, Prescription Drug Monitoring Act of 2017; S 892, Opioid Addiction Prevention Act of 2017; HR 3528, Every Prescription Conveyed Securely Act; H.R. 3545, Overdose Prevention and Patient Safety Act; S. 1850, Protecting Jessica Grubbs Legacy Act; H.R. 1271, DXM Abuse Prevention Act of 2017; H.R. 1375, Prescriber Support Act of 2017; S. 523, Budgeting for Opioid Addiction Treatment Act; S. 581, Jessies Law; S 1079, Protecting Americans from Dangerous Opioids Act;
HEALTHY KIDS Act
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
H.R. 1316, Prescription Drug Price Transparency Act; H.R. 1038, Improving Transparency and Accuracy in Medicare Part D Spending Act; S. 413, Improving Transparency and Accuracy in Medicare Part D Spending Act; H.R. 592, Pharmacy and Medically Underserved Areas Enhancement Act; S. 109, Pharmacy and Medically Underserved Areas Enhancement Act; H.R.1939 - To amend title XVIII of the Social Security Act to ensure equal access of Medicare beneficiaries to community pharmacies in underserved areas as network pharmacies under Medicare prescription drug coverage, and for other purposes; S.637 Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017; HR 394/ S 85, Restoring Access to Medication Act; HR 3921/S 1827, KIDS Act of 2017; HR 3271, Protecting Access to Diabetes Supplies Act of 2017; S. 870, Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 Discussion draft, preventing cash price disclosure restrictions under Medicare prescription drug plan contracts with pharmacies
Restoring Access to Medication Act of 2017
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
H.R. 1316, Prescription Drug Price Transparency Act; H.R. 1038, Improving Transparency and Accuracy in Medicare Part D Spending Act; S. 413, Improving Transparency and Accuracy in Medicare Part D Spending Act; H.R. 592, Pharmacy and Medically Underserved Areas Enhancement Act; S. 109, Pharmacy and Medically Underserved Areas Enhancement Act; H.R.1939 - To amend title XVIII of the Social Security Act to ensure equal access of Medicare beneficiaries to community pharmacies in underserved areas as network pharmacies under Medicare prescription drug coverage, and for other purposes; S.637 Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017; HR 394/ S 85, Restoring Access to Medication Act; HR 3921/S 1827, KIDS Act of 2017; HR 3271, Protecting Access to Diabetes Supplies Act of 2017; S. 870, Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 Discussion draft, preventing cash price disclosure restrictions under Medicare prescription drug plan contracts with pharmacies
Allowing Greater Access to Safe and Effective Contraception Act
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
Congressional Oversight of 340 B Program; Issues related to FDA implementation of The Drug Quality and Security Act related to the regulations of pharmacy compounding; Biosimilar naming; H.R. 421 Allowing Greater Access to Safe and Effective Contraception Act; H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017
Allowing Greater Access to Safe and Effective Contraception Act
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
Congressional Oversight of 340 B Program; Issues related to FDA implementation of The Drug Quality and Security Act related to the regulations of pharmacy compounding; Biosimilar naming; H.R. 421 Allowing Greater Access to Safe and Effective Contraception Act; H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017; HR 749, Lower Drug Costs through Competition Act
Allowing Greater Access to Safe and Effective Contraception Act
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
Congressional Oversight of 340 B Program; Issues related to FDA implementation of The Drug Quality and Security Act related to the regulations of pharmacy compounding; Biosimilar naming; H.R. 421 Allowing Greater Access to Safe and Effective Contraception Act
Pharmacy and Medically Underserved Areas Enhancement Act
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
H.R. 1316, Prescription Drug Price Transparency Act; H.R. 1038, Improving Transparency and Accuracy in Medicare Part D Spending Act; S. 413, Improving Transparency and Accuracy in Medicare Part D Spending Act; H.R. 592, Pharmacy and Medically Underserved Areas Enhancement Act; S. 109, Pharmacy and Medically Underserved Areas Enhancement Act; H.R.1939 - To amend title XVIII of the Social Security Act to ensure equal access of Medicare beneficiaries to community pharmacies in underserved areas as network pharmacies under Medicare prescription drug coverage, and for other purposes; S.637 Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017; HR 394/ S 85, Restoring Access to Medication Act; HR 3921/S 1827, KIDS Act of 2017; HR 3271, Protecting Access to Diabetes Supplies Act of 2017; S. 870, Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 Discussion draft, preventing cash price disclosure restrictions under Medicare prescription drug plan contracts with pharmacies
Pharmacy and Medically Underserved Areas Enhancement Act
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
H.R. 1316, Prescription Drug Price Transparency Act; H.R. 1038, Improving Transparency and Accuracy in Medicare Part D Spending Act; S. 413, Improving Transparency and Accuracy in Medicare Part D Spending Act; H.R. 592, Pharmacy and Medically Underserved Areas Enhancement Act; S. 109, Pharmacy and Medically Underserved Areas Enhancement Act; H.R.1939 - To amend title XVIII of the Social Security Act to ensure equal access of Medicare beneficiaries to community pharmacies in underserved areas as network pharmacies under Medicare prescription drug coverage, and for other purposes
Pharmacy and Medically Underserved Areas Enhancement Act
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
H.R. 1316, Prescription Drug Price Transparency Act; H.R. 1038, Improving Transparency and Accuracy in Medicare Part D Spending Act; S. 413, Improving Transparency and Accuracy in Medicare Part D Spending Act; H.R. 592, Pharmacy and Medically Underserved Areas Enhancement Act; S. 109, Pharmacy and Medically Underserved Areas Enhancement Act; H.R.1939 - To amend title XVIII of the Social Security Act to ensure equal access of Medicare beneficiaries to community pharmacies in underserved areas as network pharmacies under Medicare prescription drug coverage, and for other purposes; S.637 Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017;
Fairness to Pet Owners Act of 2017
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
Issues related to compounded pharmaceuticals for animals; H.R. 623, FairnesstoPetOwnersActof 2017
Death Tax Repeal Act of 2017
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
Unified Framework for Fixing Our Broken Tax Code; H.R. 631, Death Tax Repeal Act of 2017; S. 205, Death Tax Repeal Act of 2017
Death Tax Repeal Act of 2017
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
Small Business Tax Reform; H.R. 631, Death Tax Repeal Act of 2017; S. 205, Death Tax Repeal Act of 2017
Death Tax Repeal Act of 2017
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
Small Business Tax Reform; H.R. 631, Death Tax Repeal Act of 2017; S. 205, Death Tax Repeal Act of 2017
Lower Drug Costs through Competition Act
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
Congressional Oversight of 340 B Program; Issues related to FDA implementation of The Drug Quality and Security Act related to the regulations of pharmacy compounding; Biosimilar naming; H.R. 421 Allowing Greater Access to Safe and Effective Contraception Act; H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017; HR 749, Lower Drug Costs through Competition Act
Protecting Americans from Dangerous Opioids Act
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
Implementation of Public Law 114-198 pharmacy provisions; Implementation of Public Law 114-255 pharmacy provisions; H.R. 1854/S. 778, Prescription Drug Monitoring Act of 2017; S 892, Opioid Addiction Prevention Act of 2017; HR 3528, Every Prescription Conveyed Securely Act; H.R. 3545, Overdose Prevention and Patient Safety Act; S. 1850, Protecting Jessica Grubbs Legacy Act; H.R. 1271, DXM Abuse Prevention Act of 2017; H.R. 1375, Prescriber Support Act of 2017; S. 523, Budgeting for Opioid Addiction Treatment Act; S. 581, Jessies Law; S 1079, Protecting Americans from Dangerous Opioids Act;
Pharmacy and Medically Underserved Areas Enhancement Act
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
H.R. 1316, Prescription Drug Price Transparency Act; H.R. 1038, Improving Transparency and Accuracy in Medicare Part D Spending Act; S. 413, Improving Transparency and Accuracy in Medicare Part D Spending Act; H.R. 592, Pharmacy and Medically Underserved Areas Enhancement Act; S. 109, Pharmacy and Medically Underserved Areas Enhancement Act; H.R.1939 - To amend title XVIII of the Social Security Act to ensure equal access of Medicare beneficiaries to community pharmacies in underserved areas as network pharmacies under Medicare prescription drug coverage, and for other purposes
Pharmacy and Medically Underserved Areas Enhancement Act
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
H.R. 1316, Prescription Drug Price Transparency Act; H.R. 1038, Improving Transparency and Accuracy in Medicare Part D Spending Act; S. 413, Improving Transparency and Accuracy in Medicare Part D Spending Act; H.R. 592, Pharmacy and Medically Underserved Areas Enhancement Act; S. 109, Pharmacy and Medically Underserved Areas Enhancement Act; H.R.1939 - To amend title XVIII of the Social Security Act to ensure equal access of Medicare beneficiaries to community pharmacies in underserved areas as network pharmacies under Medicare prescription drug coverage, and for other purposes; S.637 Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017; HR 394/ S 85, Restoring Access to Medication Act; HR 3921/S 1827, KIDS Act of 2017; HR 3271, Protecting Access to Diabetes Supplies Act of 2017; S. 870, Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 Discussion draft, preventing cash price disclosure restrictions under Medicare prescription drug plan contracts with pharmacies
Pharmacy and Medically Underserved Areas Enhancement Act
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
H.R. 1316, Prescription Drug Price Transparency Act; H.R. 1038, Improving Transparency and Accuracy in Medicare Part D Spending Act; S. 413, Improving Transparency and Accuracy in Medicare Part D Spending Act; H.R. 592, Pharmacy and Medically Underserved Areas Enhancement Act; S. 109, Pharmacy and Medically Underserved Areas Enhancement Act; H.R.1939 - To amend title XVIII of the Social Security Act to ensure equal access of Medicare beneficiaries to community pharmacies in underserved areas as network pharmacies under Medicare prescription drug coverage, and for other purposes; S.637 Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017;
National Defense Authorization Act for Fiscal Year 2018
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
Supporting implementation of Sec. 745 of National Defense Authorization Act for Fiscal Year 2017; H.R. 2810 - National Defense Authorization Act for Fiscal Year 2018- Generic drug pricing transparency and TRICARE Pharmacy Benefits Provisions; S. 1519 National Defense Authorization Act for Fiscal Year 2018- Generic drug pricing transparency and TRICARE Pharmacy Benefits Provisions
National Defense Authorization Act for Fiscal Year 2018
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
Supporting implementation of Sec. 745 of National Defense Authorization Act for Fiscal Year 2017; H.R. 2810 - National Defense Authorization Act for Fiscal Year 2018- Generic drug pricing transparency and TRICARE Pharmacy Benefits Provisions; S. 1519 National Defense Authorization Act for Fiscal Year 2018- Generic drug pricing transparency and TRICARE Pharmacy Benefits Provisions
KIDS Act of 2017
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
H.R. 1316, Prescription Drug Price Transparency Act; H.R. 1038, Improving Transparency and Accuracy in Medicare Part D Spending Act; S. 413, Improving Transparency and Accuracy in Medicare Part D Spending Act; H.R. 592, Pharmacy and Medically Underserved Areas Enhancement Act; S. 109, Pharmacy and Medically Underserved Areas Enhancement Act; H.R.1939 - To amend title XVIII of the Social Security Act to ensure equal access of Medicare beneficiaries to community pharmacies in underserved areas as network pharmacies under Medicare prescription drug coverage, and for other purposes; S.637 Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017; HR 394/ S 85, Restoring Access to Medication Act; HR 3921/S 1827, KIDS Act of 2017; HR 3271, Protecting Access to Diabetes Supplies Act of 2017; S. 870, Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 Discussion draft, preventing cash price disclosure restrictions under Medicare prescription drug plan contracts with pharmacies
Protecting Jessica Grubb's Legacy Act
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
Implementation of Public Law 114-198 pharmacy provisions; Implementation of Public Law 114-255 pharmacy provisions; H.R. 1854/S. 778, Prescription Drug Monitoring Act of 2017; S 892, Opioid Addiction Prevention Act of 2017; HR 3528, Every Prescription Conveyed Securely Act; H.R. 3545, Overdose Prevention and Patient Safety Act; S. 1850, Protecting Jessica Grubbs Legacy Act; H.R. 1271, DXM Abuse Prevention Act of 2017; H.R. 1375, Prescriber Support Act of 2017; S. 523, Budgeting for Opioid Addiction Treatment Act; S. 581, Jessies Law; S 1079, Protecting Americans from Dangerous Opioids Act;
Death Tax Repeal Act of 2017
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
Small Business Tax Reform; H.R. 631, Death Tax Repeal Act of 2017; S. 205, Death Tax Repeal Act of 2017
Death Tax Repeal Act of 2017
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
Unified Framework for Fixing Our Broken Tax Code; H.R. 631, Death Tax Repeal Act of 2017; S. 205, Death Tax Repeal Act of 2017
Death Tax Repeal Act of 2017
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
Small Business Tax Reform; H.R. 631, Death Tax Repeal Act of 2017; S. 205, Death Tax Repeal Act of 2017
Obamacare Replacement Act
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
S. 222, The Obama Care Replacement Act; S. 469, Affordable and Safe Prescription Drug Importation Act; H.R. 1245, Affordable and Safe Prescription Drug Importation Act; H.R. 1776, Improving Access to Affordable Prescription Drugs Act; S. 771, Improving Access to Affordable Prescription Drugs Act; H.R. 242, Medicare Prescription Drug Price Negotiation Act of 2017; S. 41, Medicare Prescription Drug Price Negotiation Act of 2017; Drug Pricing Transparency
Obamacare Replacement Act
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
S. 222, The Obama Care Replacement Act; S. 469, Affordable and Safe Prescription Drug Importation Act; H.R. 1245, Affordable and Safe Prescription Drug Importation Act; H.R. 1776, Improving Access to Affordable Prescription Drugs Act; S. 771, Improving Access to Affordable Prescription Drugs Act; H.R. 242, Medicare Prescription Drug Price Negotiation Act of 2017; S. 41, Medicare Prescription Drug Price Negotiation Act of 2017; Drug Pricing Transparency
Obamacare Replacement Act
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
H.R. 1628, American Health Care Act; Issues related to legislation repealing and replacing the affordable care act; S. 637, Creating Transparency to Have Drug Rebates Unlocked (C-Thru) Act of 2017; S. 222, The Obama Care Replacement Act' S. 469, Affordable and Safe Prescription Drug Importation Act; H.R. 1245, Affordable and Safe Prescription Drug Importation Act; H.R. 1776, Improving Access to Affordable Prescription Drugs Act; S. 771, Improving Access to Affordable Prescription Drugs Act; H.R. 242, Medicare Prescription Drug Price Negotiation Act of 2017; S. 41, Medicare Prescription Drug Price Negotiation Act of 2017;
Medicare Prescription Drug Price Negotiation Act of 2017
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
S. 222, The Obama Care Replacement Act; S. 469, Affordable and Safe Prescription Drug Importation Act; H.R. 1245, Affordable and Safe Prescription Drug Importation Act; H.R. 1776, Improving Access to Affordable Prescription Drugs Act; S. 771, Improving Access to Affordable Prescription Drugs Act; H.R. 242, Medicare Prescription Drug Price Negotiation Act of 2017; S. 41, Medicare Prescription Drug Price Negotiation Act of 2017; Drug Pricing Transparency
Medicare Prescription Drug Price Negotiation Act of 2017
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
S. 222, The Obama Care Replacement Act; S. 469, Affordable and Safe Prescription Drug Importation Act; H.R. 1245, Affordable and Safe Prescription Drug Importation Act; H.R. 1776, Improving Access to Affordable Prescription Drugs Act; S. 771, Improving Access to Affordable Prescription Drugs Act; H.R. 242, Medicare Prescription Drug Price Negotiation Act of 2017; S. 41, Medicare Prescription Drug Price Negotiation Act of 2017; Drug Pricing Transparency
Medicare Prescription Drug Price Negotiation Act of 2017
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
H.R. 1628, American Health Care Act; Issues related to legislation repealing and replacing the affordable care act; S. 637, Creating Transparency to Have Drug Rebates Unlocked (C-Thru) Act of 2017; S. 222, The Obama Care Replacement Act' S. 469, Affordable and Safe Prescription Drug Importation Act; H.R. 1245, Affordable and Safe Prescription Drug Importation Act; H.R. 1776, Improving Access to Affordable Prescription Drugs Act; S. 771, Improving Access to Affordable Prescription Drugs Act; H.R. 242, Medicare Prescription Drug Price Negotiation Act of 2017; S. 41, Medicare Prescription Drug Price Negotiation Act of 2017;
Improving Transparency and Accuracy in Medicare Part D Spending Act
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
H.R. 1316, Prescription Drug Price Transparency Act; H.R. 1038, Improving Transparency and Accuracy in Medicare Part D Spending Act; S. 413, Improving Transparency and Accuracy in Medicare Part D Spending Act; H.R. 592, Pharmacy and Medically Underserved Areas Enhancement Act; S. 109, Pharmacy and Medically Underserved Areas Enhancement Act; H.R.1939 - To amend title XVIII of the Social Security Act to ensure equal access of Medicare beneficiaries to community pharmacies in underserved areas as network pharmacies under Medicare prescription drug coverage, and for other purposes; S.637 Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017;
Improving Transparency and Accuracy in Medicare Part D Spending Act
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
H.R. 1316, Prescription Drug Price Transparency Act; H.R. 1038, Improving Transparency and Accuracy in Medicare Part D Spending Act; S. 413, Improving Transparency and Accuracy in Medicare Part D Spending Act; H.R. 592, Pharmacy and Medically Underserved Areas Enhancement Act; S. 109, Pharmacy and Medically Underserved Areas Enhancement Act; H.R.1939 - To amend title XVIII of the Social Security Act to ensure equal access of Medicare beneficiaries to community pharmacies in underserved areas as network pharmacies under Medicare prescription drug coverage, and for other purposes
Improving Transparency and Accuracy in Medicare Part D Spending Act
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
H.R. 1316, Prescription Drug Price Transparency Act; H.R. 1038, Improving Transparency and Accuracy in Medicare Part D Spending Act; S. 413, Improving Transparency and Accuracy in Medicare Part D Spending Act; H.R. 592, Pharmacy and Medically Underserved Areas Enhancement Act; S. 109, Pharmacy and Medically Underserved Areas Enhancement Act; H.R.1939 - To amend title XVIII of the Social Security Act to ensure equal access of Medicare beneficiaries to community pharmacies in underserved areas as network pharmacies under Medicare prescription drug coverage, and for other purposes; S.637 Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017; HR 394/ S 85, Restoring Access to Medication Act; HR 3921/S 1827, KIDS Act of 2017; HR 3271, Protecting Access to Diabetes Supplies Act of 2017; S. 870, Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 Discussion draft, preventing cash price disclosure restrictions under Medicare prescription drug plan contracts with pharmacies
Affordable and Safe Prescription Drug Importation Act
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
H.R. 1628, American Health Care Act; Issues related to legislation repealing and replacing the affordable care act; S. 637, Creating Transparency to Have Drug Rebates Unlocked (C-Thru) Act of 2017; S. 222, The Obama Care Replacement Act' S. 469, Affordable and Safe Prescription Drug Importation Act; H.R. 1245, Affordable and Safe Prescription Drug Importation Act; H.R. 1776, Improving Access to Affordable Prescription Drugs Act; S. 771, Improving Access to Affordable Prescription Drugs Act; H.R. 242, Medicare Prescription Drug Price Negotiation Act of 2017; S. 41, Medicare Prescription Drug Price Negotiation Act of 2017;
Affordable and Safe Prescription Drug Importation Act
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
S. 222, The Obama Care Replacement Act; S. 469, Affordable and Safe Prescription Drug Importation Act; H.R. 1245, Affordable and Safe Prescription Drug Importation Act; H.R. 1776, Improving Access to Affordable Prescription Drugs Act; S. 771, Improving Access to Affordable Prescription Drugs Act; H.R. 242, Medicare Prescription Drug Price Negotiation Act of 2017; S. 41, Medicare Prescription Drug Price Negotiation Act of 2017; Drug Pricing Transparency
Affordable and Safe Prescription Drug Importation Act
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
S. 222, The Obama Care Replacement Act; S. 469, Affordable and Safe Prescription Drug Importation Act; H.R. 1245, Affordable and Safe Prescription Drug Importation Act; H.R. 1776, Improving Access to Affordable Prescription Drugs Act; S. 771, Improving Access to Affordable Prescription Drugs Act; H.R. 242, Medicare Prescription Drug Price Negotiation Act of 2017; S. 41, Medicare Prescription Drug Price Negotiation Act of 2017; Drug Pricing Transparency
Budgeting for Opioid Addiction Treatment Act
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
Implementation of Public Law 114-198 pharmacy provisions; Implementation of Public Law 114-255 pharmacy provisions; H.R. 1854/S. 778, Prescription Drug Monitoring Act of 2017; S 892, Opioid Addiction Prevention Act of 2017; HR 3528, Every Prescription Conveyed Securely Act; H.R. 3545, Overdose Prevention and Patient Safety Act; S. 1850, Protecting Jessica Grubbs Legacy Act; H.R. 1271, DXM Abuse Prevention Act of 2017; H.R. 1375, Prescriber Support Act of 2017; S. 523, Budgeting for Opioid Addiction Treatment Act; S. 581, Jessies Law; S 1079, Protecting Americans from Dangerous Opioids Act;
Jessie's Law
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
Implementation of Public Law 114-198 pharmacy provisions; Implementation of Public Law 114-255 pharmacy provisions; H.R. 1854/S. 778, Prescription Drug Monitoring Act of 2017; S 892, Opioid Addiction Prevention Act of 2017; HR 3528, Every Prescription Conveyed Securely Act; H.R. 3545, Overdose Prevention and Patient Safety Act; S. 1850, Protecting Jessica Grubbs Legacy Act; H.R. 1271, DXM Abuse Prevention Act of 2017; H.R. 1375, Prescriber Support Act of 2017; S. 523, Budgeting for Opioid Addiction Treatment Act; S. 581, Jessies Law; S 1079, Protecting Americans from Dangerous Opioids Act;
Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
H.R. 1316, Prescription Drug Price Transparency Act; H.R. 1038, Improving Transparency and Accuracy in Medicare Part D Spending Act; S. 413, Improving Transparency and Accuracy in Medicare Part D Spending Act; H.R. 592, Pharmacy and Medically Underserved Areas Enhancement Act; S. 109, Pharmacy and Medically Underserved Areas Enhancement Act; H.R.1939 - To amend title XVIII of the Social Security Act to ensure equal access of Medicare beneficiaries to community pharmacies in underserved areas as network pharmacies under Medicare prescription drug coverage, and for other purposes; S.637 Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017; HR 394/ S 85, Restoring Access to Medication Act; HR 3921/S 1827, KIDS Act of 2017; HR 3271, Protecting Access to Diabetes Supplies Act of 2017; S. 870, Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 Discussion draft, preventing cash price disclosure restrictions under Medicare prescription drug plan contracts with pharmacies
Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
H.R. 1316, Prescription Drug Price Transparency Act; H.R. 1038, Improving Transparency and Accuracy in Medicare Part D Spending Act; S. 413, Improving Transparency and Accuracy in Medicare Part D Spending Act; H.R. 592, Pharmacy and Medically Underserved Areas Enhancement Act; S. 109, Pharmacy and Medically Underserved Areas Enhancement Act; H.R.1939 - To amend title XVIII of the Social Security Act to ensure equal access of Medicare beneficiaries to community pharmacies in underserved areas as network pharmacies under Medicare prescription drug coverage, and for other purposes; S.637 Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017;
Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
H.R. 1628, American Health Care Act; Issues related to legislation repealing and replacing the affordable care act; S. 637, Creating Transparency to Have Drug Rebates Unlocked (C-Thru) Act of 2017; S. 222, The Obama Care Replacement Act' S. 469, Affordable and Safe Prescription Drug Importation Act; H.R. 1245, Affordable and Safe Prescription Drug Importation Act; H.R. 1776, Improving Access to Affordable Prescription Drugs Act; S. 771, Improving Access to Affordable Prescription Drugs Act; H.R. 242, Medicare Prescription Drug Price Negotiation Act of 2017; S. 41, Medicare Prescription Drug Price Negotiation Act of 2017;
Improving Access To Affordable Prescription Drugs Act
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
H.R. 1628, American Health Care Act; Issues related to legislation repealing and replacing the affordable care act; S. 637, Creating Transparency to Have Drug Rebates Unlocked (C-Thru) Act of 2017; S. 222, The Obama Care Replacement Act' S. 469, Affordable and Safe Prescription Drug Importation Act; H.R. 1245, Affordable and Safe Prescription Drug Importation Act; H.R. 1776, Improving Access to Affordable Prescription Drugs Act; S. 771, Improving Access to Affordable Prescription Drugs Act; H.R. 242, Medicare Prescription Drug Price Negotiation Act of 2017; S. 41, Medicare Prescription Drug Price Negotiation Act of 2017;
Improving Access To Affordable Prescription Drugs Act
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
S. 222, The Obama Care Replacement Act; S. 469, Affordable and Safe Prescription Drug Importation Act; H.R. 1245, Affordable and Safe Prescription Drug Importation Act; H.R. 1776, Improving Access to Affordable Prescription Drugs Act; S. 771, Improving Access to Affordable Prescription Drugs Act; H.R. 242, Medicare Prescription Drug Price Negotiation Act of 2017; S. 41, Medicare Prescription Drug Price Negotiation Act of 2017; Drug Pricing Transparency
Improving Access To Affordable Prescription Drugs Act
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
S. 222, The Obama Care Replacement Act; S. 469, Affordable and Safe Prescription Drug Importation Act; H.R. 1245, Affordable and Safe Prescription Drug Importation Act; H.R. 1776, Improving Access to Affordable Prescription Drugs Act; S. 771, Improving Access to Affordable Prescription Drugs Act; H.R. 242, Medicare Prescription Drug Price Negotiation Act of 2017; S. 41, Medicare Prescription Drug Price Negotiation Act of 2017; Drug Pricing Transparency
Prescription Drug Monitoring Act of 2017
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
Implementation of Public Law 114-198 pharmacy provisions; Implementation of Public Law 114-255 pharmacy provisions; H.R. 1854/S. 778, Prescription Drug Monitoring Act of 2017; S 892, Opioid Addiction Prevention Act of 2017; HR 3528, Every Prescription Conveyed Securely Act; H.R. 3545, Overdose Prevention and Patient Safety Act; S. 1850, Protecting Jessica Grubbs Legacy Act; H.R. 1271, DXM Abuse Prevention Act of 2017; H.R. 1375, Prescriber Support Act of 2017; S. 523, Budgeting for Opioid Addiction Treatment Act; S. 581, Jessies Law; S 1079, Protecting Americans from Dangerous Opioids Act;
Prescription Drug Monitoring Act of 2017
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
Implementation of Public Law 114-198 pharmacy provisions; Implementation of Public Law 114-255 pharmacy provisions; S. 778, the Prescription Drug Monitoring Act of 2017
Restoring Access to Medication Act of 2017
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
H.R. 1316, Prescription Drug Price Transparency Act; H.R. 1038, Improving Transparency and Accuracy in Medicare Part D Spending Act; S. 413, Improving Transparency and Accuracy in Medicare Part D Spending Act; H.R. 592, Pharmacy and Medically Underserved Areas Enhancement Act; S. 109, Pharmacy and Medically Underserved Areas Enhancement Act; H.R.1939 - To amend title XVIII of the Social Security Act to ensure equal access of Medicare beneficiaries to community pharmacies in underserved areas as network pharmacies under Medicare prescription drug coverage, and for other purposes; S.637 Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017; HR 394/ S 85, Restoring Access to Medication Act; HR 3921/S 1827, KIDS Act of 2017; HR 3271, Protecting Access to Diabetes Supplies Act of 2017; S. 870, Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 Discussion draft, preventing cash price disclosure restrictions under Medicare prescription drug plan contracts with pharmacies
Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
H.R. 1316, Prescription Drug Price Transparency Act; H.R. 1038, Improving Transparency and Accuracy in Medicare Part D Spending Act; S. 413, Improving Transparency and Accuracy in Medicare Part D Spending Act; H.R. 592, Pharmacy and Medically Underserved Areas Enhancement Act; S. 109, Pharmacy and Medically Underserved Areas Enhancement Act; H.R.1939 - To amend title XVIII of the Social Security Act to ensure equal access of Medicare beneficiaries to community pharmacies in underserved areas as network pharmacies under Medicare prescription drug coverage, and for other purposes; S.637 Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017; HR 394/ S 85, Restoring Access to Medication Act; HR 3921/S 1827, KIDS Act of 2017; HR 3271, Protecting Access to Diabetes Supplies Act of 2017; S. 870, Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 Discussion draft, preventing cash price disclosure restrictions under Medicare prescription drug plan contracts with pharmacies
Opioid Addiction Prevention Act of 2017
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
Implementation of Public Law 114-198 pharmacy provisions; Implementation of Public Law 114-255 pharmacy provisions; H.R. 1854/S. 778, Prescription Drug Monitoring Act of 2017; S 892, Opioid Addiction Prevention Act of 2017; HR 3528, Every Prescription Conveyed Securely Act; H.R. 3545, Overdose Prevention and Patient Safety Act; S. 1850, Protecting Jessica Grubbs Legacy Act; H.R. 1271, DXM Abuse Prevention Act of 2017; H.R. 1375, Prescriber Support Act of 2017; S. 523, Budgeting for Opioid Addiction Treatment Act; S. 581, Jessies Law; S 1079, Protecting Americans from Dangerous Opioids Act;
FDA Reauthorization Act of 2017
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act; Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, specifically FDA funding for implementation of the Drug Quality and Security Act.; H.R. 1628, American Health Care Act of 2017; Better Care Reconciliation Act; H.R. 2430 the FDA Reauthorization Act (FDARA) of 2017; S.934 FDA Reauthorization Act of 2017;
FDA Reauthorization Act of 2017
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act; H.amdt. 278, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, specifically FDA funding for implementation of the Drug Quality and Security Act.; H.R. 1628, American Health Care Act of 2017; Better Care Reconciliation Act; H.R. 2430 the FDA Reauthorization Act (FDARA) of 2017; S.934 FDA Reauthorization Act of 2017;
Protecting the Integrity of Medicare Act of 2015
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
S. 776 - Medication Therapy Empowerment Act of 2015; H.R. 1021 - Protecting the Management Integrity of Medicare Act of 2015; H.R. 1270 - Restoring Access to Medication Act of 2015; S. 709- Restoring Access to Medication Act of 2015; H.R. 2- Medicare Access and Chip Reauthorization Act of 2015; H.R. 793 - Ensuring Seniors Access to Local Pharmacies Act of 2015; S. 1190 -Ensuring Seniors Access to Local Pharmacies Act of 2015; S. 314 - Pharmacy and Medically Underserved Areas Enhancement Act; H.R. 592 - Pharmacy and Medically Underserved Areas Enhancement Act;
Protecting the Integrity of Medicare Act of 2015
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
S. 776 - Medication Therapy Empowerment Act of 2015; H.R. 1021 - Protecting the Management Integrity of Medicare Act of 2015; H.R. 1270 - Restoring Access to Medication Act of 2015; S. 709- Restoring Access to Medication Act of 2015; H.R. 2- Medicare Access and Chip Reauthorization Act of 2015; H.R. 793 - Ensuring Seniors Access to Local Pharmacies Act of 2015; S. 1190 -Ensuring Seniors Access to Local Pharmacies Act of 2015; S. 314 - Pharmacy and Medically Underserved Areas Enhancement Act; H.R. 592 - Pharmacy and Medically Underserved Areas Enhancement Act;
Protecting the Integrity of Medicare Act of 2015
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
S. 776 - Medication Therapy Empowerment Act of 2015; H.R. 1021 - Protecting the Management Integrity of Medicare Act of 2015; H.R. 1270 - Restoring Access to Medication Act of 2015; S. 709- Restoring Access to Medication Act of 2015; H.R. 2- Medicare Access and Chip Reauthorization Act of 2015; H.R. 793 - Ensuring Seniors Access to Local Pharmacies Act of 2015; S. 1190 -Ensuring Seniors Access to Local Pharmacies Act of 2015; S. 314 - Pharmacy and Medically Underserved Areas Enhancement Act; H.R. 592 - Pharmacy and Medically Underserved Areas Enhancement Act;
Protecting the Integrity of Medicare Act of 2015
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
S. 776 - Medication Therapy Empowerment Act of 2015; H.R. 1021 - Protecting the Management Integrity of Medicare Act of 2015; H.R. 1270 - Restoring Access to Medication Act of 2015; S. 709- Restoring Access to Medication Act of 2015; H.R. 2- Medicare Access and Chip Reauthorization Act of 2015; H.R. 793 - Ensuring Seniors Access to Local Pharmacies Act of 2015; S. 1190 -Ensuring Seniors Access to Local Pharmacies Act of 2015; S. 314 - Pharmacy and Medically Underserved Areas Enhancement Act; H.R. 592 - Pharmacy and Medically Underserved Areas Enhancement Act; H.R. 5951/S. 3308 - Improving Transparency and Accuracy in Medicare Part D Spending Act
Restoring Access to Medication and Improving Health Savings Act of 2016
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
S. 776 - Medication Therapy Empowerment Act of 2015; H.R. 1021 - Protecting the Management Integrity of Medicare Act of 2015; H.R. 1270 - Restoring Access to Medication Act of 2015; S. 709- Restoring Access to Medication Act of 2015; H.R. 2- Medicare Access and Chip Reauthorization Act of 2015; H.R. 793 - Ensuring Seniors Access to Local Pharmacies Act of 2015; S. 1190 -Ensuring Seniors Access to Local Pharmacies Act of 2015; S. 314 - Pharmacy and Medically Underserved Areas Enhancement Act; H.R. 592 - Pharmacy and Medically Underserved Areas Enhancement Act;
Restoring Access to Medication and Improving Health Savings Act of 2016
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
S. 776 - Medication Therapy Empowerment Act of 2015; H.R. 1021 - Protecting the Management Integrity of Medicare Act of 2015; H.R. 1270 - Restoring Access to Medication Act of 2015; S. 709- Restoring Access to Medication Act of 2015; H.R. 2- Medicare Access and Chip Reauthorization Act of 2015; H.R. 793 - Ensuring Seniors Access to Local Pharmacies Act of 2015; S. 1190 -Ensuring Seniors Access to Local Pharmacies Act of 2015; S. 314 - Pharmacy and Medically Underserved Areas Enhancement Act; H.R. 592 - Pharmacy and Medically Underserved Areas Enhancement Act;
Restoring Access to Medication and Improving Health Savings Act of 2016
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
S. 776 - Medication Therapy Empowerment Act of 2015; H.R. 1021 - Protecting the Management Integrity of Medicare Act of 2015; H.R. 1270 - Restoring Access to Medication Act of 2015; S. 709- Restoring Access to Medication Act of 2015; H.R. 2- Medicare Access and Chip Reauthorization Act of 2015; H.R. 793 - Ensuring Seniors Access to Local Pharmacies Act of 2015; S. 1190 -Ensuring Seniors Access to Local Pharmacies Act of 2015; S. 314 - Pharmacy and Medically Underserved Areas Enhancement Act; H.R. 592 - Pharmacy and Medically Underserved Areas Enhancement Act;
Restoring Access to Medication and Improving Health Savings Act of 2016
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
S. 776 - Medication Therapy Empowerment Act of 2015; H.R. 1021 - Protecting the Management Integrity of Medicare Act of 2015; H.R. 1270 - Restoring Access to Medication Act of 2015; S. 709- Restoring Access to Medication Act of 2015; H.R. 2- Medicare Access and Chip Reauthorization Act of 2015; H.R. 793 - Ensuring Seniors Access to Local Pharmacies Act of 2015; S. 1190 -Ensuring Seniors Access to Local Pharmacies Act of 2015; S. 314 - Pharmacy and Medically Underserved Areas Enhancement Act; H.R. 592 - Pharmacy and Medically Underserved Areas Enhancement Act; H.R. 5951/S. 3308 - Improving Transparency and Accuracy in Medicare Part D Spending Act
Medicare Access and CHIP Reauthorization Act of 2015
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
S. 776 - Medication Therapy Empowerment Act of 2015; H.R. 1021 - Protecting the Management Integrity of Medicare Act of 2015; H.R. 1270 - Restoring Access to Medication Act of 2015; S. 709- Restoring Access to Medication Act of 2015; H.R. 2- Medicare Access and Chip Reauthorization Act of 2015; H.R. 793 - Ensuring Seniors Access to Local Pharmacies Act of 2015; S. 1190 -Ensuring Seniors Access to Local Pharmacies Act of 2015; S. 314 - Pharmacy and Medically Underserved Areas Enhancement Act; H.R. 592 - Pharmacy and Medically Underserved Areas Enhancement Act;
Medicare Access and CHIP Reauthorization Act of 2015
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
S. 776 - Medication Therapy Empowerment Act of 2015; H.R. 1021 - Protecting the Management Integrity of Medicare Act of 2015; H.R. 1270 - Restoring Access to Medication Act of 2015; S. 709- Restoring Access to Medication Act of 2015; H.R. 2- Medicare Access and Chip Reauthorization Act of 2015; H.R. 793 - Ensuring Seniors Access to Local Pharmacies Act of 2015; S. 1190 -Ensuring Seniors Access to Local Pharmacies Act of 2015; S. 314 - Pharmacy and Medically Underserved Areas Enhancement Act; H.R. 592 - Pharmacy and Medically Underserved Areas Enhancement Act;
Medicare Access and CHIP Reauthorization Act of 2015
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
S. 776 - Medication Therapy Empowerment Act of 2015; H.R. 1021 - Protecting the Management Integrity of Medicare Act of 2015; H.R. 1270 - Restoring Access to Medication Act of 2015; S. 709- Restoring Access to Medication Act of 2015; H.R. 2- Medicare Access and Chip Reauthorization Act of 2015; H.R. 793 - Ensuring Seniors Access to Local Pharmacies Act of 2015; S. 1190 -Ensuring Seniors Access to Local Pharmacies Act of 2015; S. 314 - Pharmacy and Medically Underserved Areas Enhancement Act; H.R. 592 - Pharmacy and Medically Underserved Areas Enhancement Act;
Medicare Access and CHIP Reauthorization Act of 2015
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
S. 776 - Medication Therapy Empowerment Act of 2015; H.R. 1021 - Protecting the Management Integrity of Medicare Act of 2015; H.R. 1270 - Restoring Access to Medication Act of 2015; S. 709- Restoring Access to Medication Act of 2015; H.R. 2- Medicare Access and Chip Reauthorization Act of 2015; H.R. 793 - Ensuring Seniors Access to Local Pharmacies Act of 2015; S. 1190 -Ensuring Seniors Access to Local Pharmacies Act of 2015; S. 314 - Pharmacy and Medically Underserved Areas Enhancement Act; H.R. 592 - Pharmacy and Medically Underserved Areas Enhancement Act; H.R. 5951/S. 3308 - Improving Transparency and Accuracy in Medicare Part D Spending Act
MAC Transparency Act
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
H.R. 244 - MAC Transparency Act of 2015; Congressional Oversight of 340 B Program; S. 1406 - Saving Access to Compounding Medications for Special Needs Patients Act; Direct and Indirect Remuneration fees (DIR); Issues related to FDA implementation of The Drug Quality and Security Act related to compounding
MAC Transparency Act
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
H.R. 244 - MAC Transparency Act of 2015; Congressional Oversight of 340 B Program; S. 1406 - Saving Access to Compounding Medications for Special Needs Patients Act; Issues related to FDA implementation of The Drug Quality and Security Act related to compounding; Issues Related to Direct and Indirect Renumeration (DIR) Fees;
MAC Transparency Act
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
H.R. 244 - MAC Transparency Act of 2015; Congressional Oversight of 340 B Program; S. 1406 - Saving Access to Compounding Medications for Special Needs Patients Act; Issues related to FDA implementation of The Drug Quality and Security Act related to compounding; Issues Related to Direct and Indirect Renumeration (DIR) Fees; H.R. 5951/S. 3308 - Improving Transparency and Accuracy in Medicare Part D Spending Act
MAC Transparency Act
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
H.R. 244 - MAC Transparency Act of 2015; Congressional Oversight of 340 B Program; S. 1406 - Saving Access to Compounding Medications for Special Needs Patients Act; Issues related to FDA implementation of The Drug Quality and Security Act related to compounding; Issues Related to Direct and Indirect Renumeration (DIR) Fees
H.R. 1316, Prescription Drug Price Transparency Act; H.R. 1038, Improving Transparency and Accuracy in Medicare Part D Spending Act; S. 413, Improving Transparency and Accuracy in Medicare Part D Spending Act; H.R. 592, Pharmacy and Medically Underserved Areas Enhancement Act; S. 109, Pharmacy and Medically Underserved Areas Enhancement Act; H.R.1939 - To amend title XVIII of the Social Security Act to ensure equal access of Medicare beneficiaries to community pharmacies in underserved areas as network pharmacies under Medicare prescription drug coverage, and for other purposes; S.637 Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017; HR 394/ S 85, Restoring Access to Medication Act; HR 3921/S 1827, KIDS Act of 2017; HR 3271, Protecting Access to Diabetes Supplies Act of 2017; S. 870, Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 Discussion draft, preventing cash price disclosure restrictions under Medicare prescription drug plan contracts with pharmacies
Congressional Oversight of 340 B Program; Issues related to FDA implementation of The Drug Quality and Security Act related to the regulations of pharmacy compounding; Biosimilar naming; H.R. 421 Allowing Greater Access to Safe and Effective Contraception Act; H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017; HR 749, Lower Drug Costs through Competition Act
Implementation of Public Law 114-198 pharmacy provisions; Implementation of Public Law 114-255 pharmacy provisions; H.R. 1854/S. 778, Prescription Drug Monitoring Act of 2017; S 892, Opioid Addiction Prevention Act of 2017; HR 3528, Every Prescription Conveyed Securely Act; H.R. 3545, Overdose Prevention and Patient Safety Act; S. 1850, Protecting Jessica Grubbs Legacy Act; H.R. 1271, DXM Abuse Prevention Act of 2017; H.R. 1375, Prescriber Support Act of 2017; S. 523, Budgeting for Opioid Addiction Treatment Act; S. 581, Jessies Law; S 1079, Protecting Americans from Dangerous Opioids Act;
S. 222, The Obama Care Replacement Act; S. 469, Affordable and Safe Prescription Drug Importation Act; H.R. 1245, Affordable and Safe Prescription Drug Importation Act; H.R. 1776, Improving Access to Affordable Prescription Drugs Act; S. 771, Improving Access to Affordable Prescription Drugs Act; H.R. 242, Medicare Prescription Drug Price Negotiation Act of 2017; S. 41, Medicare Prescription Drug Price Negotiation Act of 2017; Drug Pricing Transparency
Issues related to compounded pharmaceuticals for animals; H.R. 623, FairnesstoPetOwnersActof 2017
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act; H.amdt. 278, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, specifically FDA funding for implementation of the Drug Quality and Security Act.; H.R. 1628, American Health Care Act of 2017; Better Care Reconciliation Act; H.R. 2430 the FDA Reauthorization Act (FDARA) of 2017; S.934 FDA Reauthorization Act of 2017;
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Natl Economic Council (NEC), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), Office of Personnel Management (OPM), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Treasury, Dept of, White House Office
NATIONAL COMMUNITY PHARMACISTS ASSOCIATION via NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
2017 · second_quarter · Q2
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act; Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, specifically FDA funding for implementation of the Drug Quality and Security Act.; H.R. 1628, American Health Care Act of 2017; Better Care Reconciliation Act; H.R. 2430 the FDA Reauthorization Act (FDARA) of 2017; S.934 FDA Reauthorization Act of 2017;
Implementation of Public Law 114-198 pharmacy provisions; Implementation of Public Law 114-255 pharmacy provisions; S. 778, the Prescription Drug Monitoring Act of 2017
Issues related to compounded pharmaceuticals for animals;
Congressional Oversight of 340 B Program; Issues related to FDA implementation of The Drug Quality and Security Act related to the regulations of pharmacy compounding; Biosimilar naming; H.R. 421 Allowing Greater Access to Safe and Effective Contraception Act; H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017
Small Business Tax Reform; H.R. 631, Death Tax Repeal Act of 2017; S. 205, Death Tax Repeal Act of 2017
H.R. 1316, Prescription Drug Price Transparency Act; H.R. 1038, Improving Transparency and Accuracy in Medicare Part D Spending Act; S. 413, Improving Transparency and Accuracy in Medicare Part D Spending Act; H.R. 592, Pharmacy and Medically Underserved Areas Enhancement Act; S. 109, Pharmacy and Medically Underserved Areas Enhancement Act; H.R.1939 - To amend title XVIII of the Social Security Act to ensure equal access of Medicare beneficiaries to community pharmacies in underserved areas as network pharmacies under Medicare prescription drug coverage, and for other purposes; S.637 Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017;
Supporting implementation of Sec. 745 of National Defense Authorization Act for Fiscal Year 2017; H.R. 2810 - National Defense Authorization Act for Fiscal Year 2018- Generic drug pricing transparency and TRICARE Pharmacy Benefits Provisions; S. 1519 National Defense Authorization Act for Fiscal Year 2018- Generic drug pricing transparency and TRICARE Pharmacy Benefits Provisions
S. 222, The Obama Care Replacement Act; S. 469, Affordable and Safe Prescription Drug Importation Act; H.R. 1245, Affordable and Safe Prescription Drug Importation Act; H.R. 1776, Improving Access to Affordable Prescription Drugs Act; S. 771, Improving Access to Affordable Prescription Drugs Act; H.R. 242, Medicare Prescription Drug Price Negotiation Act of 2017; S. 41, Medicare Prescription Drug Price Negotiation Act of 2017; Drug Pricing Transparency
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), Office of Personnel Management (OPM), SENATE, White House Office
NATIONAL COMMUNITY PHARMACISTS ASSOCIATION via NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
2017 · first_quarter · Q1
Issues related to compounded pharmaceuticals for animals;
H.R. 1316, Prescription Drug Price Transparency Act; H.R. 1038, Improving Transparency and Accuracy in Medicare Part D Spending Act; S. 413, Improving Transparency and Accuracy in Medicare Part D Spending Act; H.R. 592, Pharmacy and Medically Underserved Areas Enhancement Act; S. 109, Pharmacy and Medically Underserved Areas Enhancement Act; H.R.1939 - To amend title XVIII of the Social Security Act to ensure equal access of Medicare beneficiaries to community pharmacies in underserved areas as network pharmacies under Medicare prescription drug coverage, and for other purposes
Small Business Tax Reform; H.R. 631, Death Tax Repeal Act of 2017; S. 205, Death Tax Repeal Act of 2017
Congressional Oversight of 340 B Program; Issues related to FDA implementation of The Drug Quality and Security Act related to the regulations of pharmacy compounding; Biosimilar naming; H.R. 421 Allowing Greater Access to Safe and Effective Contraception Act
TRICARE Pharmacy Benefit Provisions; Supporting implementation of Sec. 745 of National Defense Authorization Act for Fiscal Year 2017;
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act; Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, specifically FDA funding for implementation of the Drug Quality and Security Act.
H.R. 1628, American Health Care Act; Issues related to legislation repealing and replacing the affordable care act; S. 637, Creating Transparency to Have Drug Rebates Unlocked (C-Thru) Act of 2017; S. 222, The Obama Care Replacement Act' S. 469, Affordable and Safe Prescription Drug Importation Act; H.R. 1245, Affordable and Safe Prescription Drug Importation Act; H.R. 1776, Improving Access to Affordable Prescription Drugs Act; S. 771, Improving Access to Affordable Prescription Drugs Act; H.R. 242, Medicare Prescription Drug Price Negotiation Act of 2017; S. 41, Medicare Prescription Drug Price Negotiation Act of 2017;
Implementation of Public Law 114-198 pharmacy provisions; Implementation of Public Law 114-255 pharmacy provisions;
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), Office of Personnel Management (OPM), SENATE, White House Office
NATIONAL COMMUNITY PHARMACISTS ASSOCIATION via NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
2016 · fourth_quarter · Q4
H.R. 471 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015; S. 483 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015; Implementation of Public Law 114-198; S.524 - Comprehensive Addiction and Recovery Act of 2016; H.R.953 - Comprehensive Addiction and Recovery Act of 2015;
Small Business Tax Reform
TRICARE Pharmacy Benefit Provisions; National Defense Authorization Act H.R. 4909 - National Defense Authorization Act; S. 2943 - National Defense Authorization Act
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act; Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, specifically FDA funding for implementation of the Drug Quality and Security Act
H.R. 244 - MAC Transparency Act of 2015; Congressional Oversight of 340 B Program; S. 1406 - Saving Access to Compounding Medications for Special Needs Patients Act; Issues related to FDA implementation of The Drug Quality and Security Act related to compounding; Issues Related to Direct and Indirect Renumeration (DIR) Fees;
H.R. 6 - 21st Century Cures Act; Senate HELP Innovation Initiative: How to Get Medical Devices, Drugs, Treatments From Discovery to the Medicine Cabinet S. 1913 - Stopping Medication Abuse and Protecting Seniors Act of 2015
S. 776 - Medication Therapy Empowerment Act of 2015; H.R. 1021 - Protecting the Management Integrity of Medicare Act of 2015; H.R. 1270 - Restoring Access to Medication Act of 2015; S. 709- Restoring Access to Medication Act of 2015; H.R. 2- Medicare Access and Chip Reauthorization Act of 2015; H.R. 793 - Ensuring Seniors Access to Local Pharmacies Act of 2015; S. 1190 -Ensuring Seniors Access to Local Pharmacies Act of 2015; S. 314 - Pharmacy and Medically Underserved Areas Enhancement Act; H.R. 592 - Pharmacy and Medically Underserved Areas Enhancement Act; H.R. 5951/S. 3308 - Improving Transparency and Accuracy in Medicare Part D Spending Act
Issues related to compounded pharmaceuticals for animals; S. 1200 - Fairness to Pet Owners Act 2015; H.R. 3174 - Fairness to Pet Owners Act of 2015;
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), Office of Personnel Management (OPM), SENATE
NATIONAL COMMUNITY PHARMACISTS ASSOCIATION via NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
2016 · third_quarter · Q3
H.R. 6 - 21st Century Cures Act; Senate HELP Innovation Initiative: How to Get Medical Devices, Drugs, Treatments From Discovery to the Medicine Cabinet S. 1913 - Stopping Medication Abuse and Protecting Seniors Act of 2015
H.R. 244 - MAC Transparency Act of 2015; Congressional Oversight of 340 B Program; S. 1406 - Saving Access to Compounding Medications for Special Needs Patients Act; Issues related to FDA implementation of The Drug Quality and Security Act related to compounding; Issues Related to Direct and Indirect Renumeration (DIR) Fees; H.R. 5951/S. 3308 - Improving Transparency and Accuracy in Medicare Part D Spending Act
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act; Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, specifically FDA funding for implementation of the Drug Quality and Security Act
TRICARE Pharmacy Benefit Provisions; National Defense Authorization Act H.R. 4909 - National Defense Authorization Act; S. 2943 - National Defense Authorization Act
Issues related to compounded pharmaceuticals for animals; S. 1200 - Fairness to Pet Owners Act 2015; H.R. 3174 - Fairness to Pet Owners Act of 2015;
S. 776 - Medication Therapy Empowerment Act of 2015; H.R. 1021 - Protecting the Management Integrity of Medicare Act of 2015; H.R. 1270 - Restoring Access to Medication Act of 2015; S. 709- Restoring Access to Medication Act of 2015; H.R. 2- Medicare Access and Chip Reauthorization Act of 2015; H.R. 793 - Ensuring Seniors Access to Local Pharmacies Act of 2015; S. 1190 -Ensuring Seniors Access to Local Pharmacies Act of 2015; S. 314 - Pharmacy and Medically Underserved Areas Enhancement Act; H.R. 592 - Pharmacy and Medically Underserved Areas Enhancement Act;
Small Business Tax Reform
H.R. 471 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015; S. 483 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015; Implementation of Public Law 114-198; S.524 - Comprehensive Addiction and Recovery Act of 2016; H.R.953 - Comprehensive Addiction and Recovery Act of 2015; H.R. 3250 - DXM Abuse Prevention Act; H.R. 5951/S. 3308 - Improving Transparency and Accuracy in Medicare Part D Spending Act
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), Office of Personnel Management (OPM), SENATE
NATIONAL COMMUNITY PHARMACISTS ASSOCIATION via NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
2016 · second_quarter · Q2
H.R. 471 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015; S. 483 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015; S.524 - Comprehensive Addiction and Recovery Act of 2016; H.R.953 - Comprehensive Addiction and Recovery Act of 2015; H.R. 3250 - DXM Abuse Prevention Act;
H.R. 244 - MAC Transparency Act of 2015; Congressional Oversight of 340 B Program; S. 1406 - Saving Access to Compounding Medications for Special Needs Patients Act; Issues related to FDA implementation of The Drug Quality and Security Act related to compounding; Issues Related to Direct and Indirect Renumeration (DIR) Fees
NATIONAL COMMUNITY PHARMACISTS ASSOCIATION via NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
2016 · first_quarter · Q1
Small Business Tax Reform
National Defense Authorization Act for FY2017, TRICARE Pharmacy Benefit Provisions
Issues related to compounded pharmaceuticals for animals; S. 1200 - Fairness to Pet Owners Act 2015; H.R. 3174 - Fairness to Pet Owners Act of 2015;
NATIONAL COMMUNITY PHARMACISTS ASSOCIATION via NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
2015 · fourth_quarter · Q4
H.R. 1735- National Dense Authorization Act for FY2016, TRICARE Pharmacy Benefit/Provisions; S. 1376 National Defense Authorization Act for FY2016, TRICARE Pharmacy Benefit/Provisions
H.R. 471 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015; S. 483 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015
H.R. 6 - 21st Century Cures Act; Senate HELP Innovation Initiative: How to Get Medical Devices, Drugs, Treatments From Discovery to the Medicine Cabinet S. 1913 - Stopping Medication Abuse and Protecting Seniors Act of 2015
NATIONAL COMMUNITY PHARMACISTS ASSOCIATION via NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
2015 · third_quarter · Q3
H.R. 6 - 21st Century Cures Act; Senate HELP Innovation Initiative: How to Get Medical Devices, Drugs, Treatments From Discovery to the Medicine Cabinet S. 1913 - Stopping Medication Abuse and Protecting Seniors Act of 2015
Small Business Tax Reform
H.R. 471 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015; S. 483 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015
NATIONAL COMMUNITY PHARMACISTS ASSOCIATION via NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
2015 · second_quarter · Q2
H.R. 471 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015; S. 483 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015
Small Business Tax Reform
H.R. 6 - 21st Century Cures Act; Senate HELP Innovation Initiative: How to Get Medical Devices, Drugs, Treatments From Discovery to the Medicine Cabinet
NATIONAL COMMUNITY PHARMACISTS ASSOCIATION via NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
2015 · first_quarter · Q1
H.R. 471- Ensuring Patient Access and Effective Drug Enforcement Act of 2015; S. 483 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015;
Discussion document to accelerate the discovery, development, and delivery of 21st century cures, and for other purposes;
Small Business Tax Reform;
NATIONAL COMMUNITY PHARMACISTS ASSOCIATION via NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
2014 · fourth_quarter · Q4
H.R. 1285- To Amend the Controlled Substance Act to Make Any Substance Containing Hydrocodone a Schedule II Drug; S.621- The Safe Prescribing Act of 2013; H.R. 1024- The Medication Therapy Management Empowerment Act of 2013; S. 557 Medication Therapy Empowerment Act of 2013; H.R. 1188- The Preserving Our Hometown Independent Pharmacies Act of 2013; CMS proposed and final rule on Medicare Part D; H.R. 4709- Ensuring Patient Access and Effective Drug Enforcement Act of 2014; S.2862 - Regulatory Transparency, Patient Access, and Effective Drug Enforcement Act of 2014; H.R. 4190- To Amend Title XVIII of the Social Security Act to provide for coverage under the Medicare program of pharmacist services; FDAs action on and enforcement of Public Law No: 113-54; H.R.4577 - Ensuring Seniors Access to Local Pharmacies Act of 2014; H.R.4437 - Generic Drug Pricing Fairness Act; S. 1493 - Medicare Efficient Drug Dispensing Act of 2013; Generic Drug Pricing Spikes; The SGR Repeal and Medicare Beneficiary Access Improvement Act of 2013; H.R..3979 Carl Levin and Howard P. Buck Mckeon National Defense Authorization Act for Fiscal Year 2015 (Tricare Provisions); Prescription Drug Abuse and Diversion; H.R. Res. 130-FY 2015 Continuing Resolution (though December 14, 2014); H.J. Res. 291- Making Further Continuing Appropriations for Fiscal Year 2015, And For Other Purposes (Until December 17, 2014); H.R.83 - FY2015 Omnibus; Consolidated and Further Continuing Appropriations Act; H.R. 4709 - Ensuring Patient Access and Effective Drug Enforcement Act of 2014;
NATIONAL COMMUNITY PHARMACISTS ASSOCIATION via NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
2014 · third_quarter · Q3
H.R. 1285- To Amend the Controlled Substance Act to Make Any Substance Containing Hydrocodone a Schedule II Drug; S.621- The Safe Prescribing Act of 2013; H.R. 1024- The Medication Therapy Management Empowerment Act of 2013; S. 557 Medication Therapy Empowerment Act of 2013; H.R. 1188- The Preserving Our Hometown Independent Pharmacies Act of 2013; CMS proposed and final rule on Medicare Part D; H.R. 4709- Ensuring Patient Access and Effective Drug Enforcement Act of 2014;S.2862 - Regulatory Transparency, Patient Access, and Effective Drug Enforcement Act of 2014; H.R. 4190- To Amend Title XVIII of the Social Security Act to provide for coverage under the Medicare program of pharmacist services; FDAs action on and enforcement of Public Law No: 113-54; H.R.4577 - Ensuring Seniors Access to Local Pharmacies Act of 2014; H.R.4437 - Generic Drug Pricing Fairness Act; S. 1493 - Medicare Efficient Drug Dispensing Act of 2013; Generic Drug Pricing Spikes; The SGR Repeal and Medicare Beneficiary Access Improvement Act of 2013; H.R..4435 National Defense Authorization Act for Fiscal Year 2015 (Tricare Provisions); S. 2410 National Defense Authorization Act for Fiscal Year 2015 (Tricare Provisions); Perscription Drug Abuse and Diversion; H.Con.Res 25: Establishing the budget for the United States government for Fiscal Year 2014 and setting forth appropriate budgetary levels for Fiscal Year 2015 through 2023; S.Con.Res 8: An original concurrent resolution setting forth the Congressional budget for the United States Government for Fiscal Year 2014, revising the appropriate budgetary levels for Fiscal year 2013, and setting forth the appropriate budgetary levels for Fiscal Years 2015 through 2023.
NATIONAL COMMUNITY PHARMACISTS ASSOCIATION via NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
2014 · second_quarter · Q2
S.644- The Preventing Abuse of Cough Treatments of Acts of 2013; H.R. 1285- To Amend the Controlled Substance Act to Make Any Substance Containing Hydrocodone a Schedule II Drug; S.621- The Safe Prescribing Act of 2013; H.R. 1024- The Medication Therapy Management Empowerment Act of 2013; H.R. 1188- The Preserving of Hometown Independent Pharmacies Act of 2013; CMS proposed rule on Medicare Part D; H.R. 4709- Ensuring Patient Access and Effective Drug Enforcement Act of 2014;H.R. 4190- To Amend Title XVIII of the Social Security Act to provide for coverage under the Medicare program of pharmacist services; FDAs action on and enforcement of Public Law No: 113-54; H.R.4577 - Ensuring Seniors Access to Local Pharmacies Act of 2014; H.R.4437 - Generic Drug Pricing Fairness Act; S. 1493 - Medicare Efficient Drug Dispensing Act of 2013
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), Office of Personnel Management (OPM), SENATE
NATIONAL COMMUNITY PHARMACISTS ASSOCIATION via NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
2014 · first_quarter · Q1
Fairness for Small Pharmacies in Part D Preferred Networks; Lifting Prohibition for Home Delivery of Diabetes Testing Supplies Home Delivery (H.R. 2845/S. 1935) ; S.644- The Preventing Abuse of Cough Treatments Act of 2013; H.R. 1285- To Amend the Controlled Substance Act to Make Any Substance Containing Hydrocodone a Schedule II Drug; S.621- The Safe Prescribing Act of 2013; H.R. 1024- The Medication Therapy Management Empowerment Act of 2013;H.R. 1188- The Preserving Our Hometown Independent Pharmacies Act of 2013; TRICARE Pharmacy Benefit/Provisions; Medicaid Reimbursement Cuts; PBM audit and generic pricing transparency and pricing reform; S. 867 - Medicare Prescription Drug Program Integrity and Transparency Act of 2013; CMS proposed rule on Medicare Part D; H.R. 4069 - Ensuring Patient Access and Effective Drug Enforcement Act of 2013; H.R. 4190 - To amend title XVIII of the Social Security Act to provide for coverage under the Medicare program of pharmacist services; FDAs action on and enforcement of Public Law No: 113-54.
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), Office of Personnel Management (OPM), SENATE
NATIONAL COMMUNITY PHARMACISTS ASSOCIATION via NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
2013 · fourth_quarter · Q4
H.R. 2375- Transparency and Accountability in Medicare Bidding Act of 2013; Fairness for Small Pharmacies in Preferred Networks; Repeal of National Mail Order Program for Diabetes Testing Supplies Home Delivery; S.644- The Preventing Abuse of Cough Treatments Act of 2013; H.R. 1285- To Amend the Controlled Substance Act to Make Any Substance Containing Hydrocodone a Schedule II Drug;S.621- The Safe Prescribing Act of 2013; H.R. 1024- The Medication Therapy Management Empowerment Act of 2013; H.R. 1188- The Preserving Our Hometown Independent Pharmacies Act of 2013; TRICARE Pharmacy Benefit/Provisions; Medicaid Reimbursment Cuts; PBM audit and generic pricing reform
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), Office of Personnel Management (OPM), SENATE
NATIONAL COMMUNITY PHARMACISTS ASSOCIATION via NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
2013 · third_quarter · 3A
S. 959, Pharmaceutical Compounding Quality and Accountability Act; S. 957- Drug Supply Chain Security Act; H.R. 1919- Safeguarding America's Pharmaceuticals Act of 2013; H.R. 3089- Compounding Clarity Act of 2013; H.R. 3204 - Drug Quality and Security Act; H.R. 2845 - Diabetic Testing Supply Access Act of 2013; S.867- The Medicare Prescription Drug Program Integrity and Transparency Act of 2013
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), Office of Personnel Management (OPM), SENATE
NATIONAL COMMUNITY PHARMACISTS ASSOCIATION via NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
2013 · third_quarter · Q3
S. 959, Pharmaceutical Compounding Quality and Accountability Act; S. 957- Drug Supply Chain Security Act; H.R. 1919- Safeguarding America's Pharmaceuticals Act of 2013; H.R. 3089- Compounding Clarity Act of 2013; H.R. 3204 - Drug Quality and Security Act; S.867- The Medicare Prescription Drug Program Integrity and Transparency Act of 2013
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), Office of Personnel Management (OPM), SENATE
NATIONAL COMMUNITY PHARMACISTS ASSOCIATION via NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
2013 · second_quarter · Q2
H.R. 2375- Transparency and Accountability in Medicare Bidding Act of 2013; Fairness for Small Pharmacies in Preferred Networks; Repeal of National Mail Order Program for Diabetes Testing Supplies Home Delivery; S.644- The Preventing Abuse of Cough Treatments Act of 2013; H.R. 1285- To Amend the Controlled Substance Act to Make Any Substance Containing Hydrocodone a Schedule II Drug; S.867- The Medicare Prescription Drug Program Integrity and Transparency Act of 2013;S.621- The Safe Prescribing Act of 2013; H.R. 1024- The Medication Therapy Management Empowerment Act of 2013; H.R. 1188- The Preserving Our Hometown Independent Pharmacies Act of 2013; S. 959, Pharmaceutical Compounding Quality and Accountability Act; S. 957- Drug Supply Chain Security Act; H.R.1919- Safeguarding America's Pharmaceuticals Act of 2013; Discussion House Draft Legislation on Compounded Drugs, Prescription Drug Diversion and Abuse; TRICARE Pharmacy Benefit/Provisions; Medicaid Reimbursment Cuts
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), Office of Personnel Management (OPM), SENATE
NATIONAL COMMUNITY PHARMACISTS ASSOCIATION via NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
2013 · first_quarter · Q1
HR 8, Fiscal Cliff Bill, Diabetic Testing Supplies Provisions; S.644, The Preventing Abuse of Cough Treatments Act of 2013; HR 1285, Making Hydrocodne Schedule II; S. 621, THe Safe Prescribing Act of 2013; HR 1024, The Medication Therapy Management Empowerment Act of 2013; S. 557, The Medication Therapy Management Empowerment Act of 2013; HR 1188, The Preserving our Hometown Independent Pharmacies Act of 2013 SEE ADDENDUMPharmaceutical Supply Chain Security Drug Shortages legislation; Prescription drug diversion and abuse; TRICARE Pharmacy Benefit/Provisions for inclusion in the National Defense Authorization Act; Deficit Reduction Issues; Pharmacy Preferred Networks issues
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), Office of Personnel Management (OPM), SENATE
NATIONAL COMMUNITY PHARMACISTS ASSOCIATION via NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
2012 · fourth_quarter · Q4
S.1058 and H.R. 1971, the Pharmacy Competition and Consumer Choice Act of 2011; H.R. 1936, the Medicare Access to Diabetes Act of 2011; H.R. 1946, the Preserving Our Hometown Independent Pharmacies Act of 2011; S. 1560, Nursing Home Resident Pain Relief Act of 2011; S. 1699, a bill to reduce the costs of prescription drugs under the Medicare program; S. 296, Preserving Access to Life-Savings Medications Act; Drug Cost Reduction Act; S. 2002 and H.R. 4095, Online Pharmacy Safety Act; SEE ADDENDUM S. 1251, Medicare and Medicaid FAST Act; S. 882, STOP Act; S.319, Pharmaceutical Market Access and Drug Safety Act of 2011; S. 1002, SAFE Doses Act; H.R. 4215, The Medicare Pharmacy Transparency and Fair Auditing Act; Prescription Drug User Fee Act; Pharmaceutical Supply Chain Security Drug Shortages legislation; Prescription drug diversion and abuse; TRICARE Pharmacy Benefit/Provisions for inclusion in the National Defense Authorization Act for FY2013; Medicare Part B Revalidation; Hydrocodone Issues; S. 3376, PACT Act, S. 2467 and S. 3254 and H.R. 4310, he National Defense Authorization Act for FY2013; S. 3604, Improving Dementia Care Treatment for Older Adults Act of 2012; Deficit Reduction Issues
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), Office of Personnel Management (OPM), SENATE
NATIONAL COMMUNITY PHARMACISTS ASSOCIATION via NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
2012 · third_quarter · Q3
S. 1058 and H.R. 1971, the Pharmacy Competition and Consumer Choice Act of 2011; H.R. 1936, the Medicare Access to Diabetes Act of 2011; H.R. 1946, the Preserving Our Hometown Independent Pharmacies Act of 2011; S. 1560, Nursing Home Resident Pain Relief Act of 2011; S. 1699, a bill to reduce the costs of prescription drugs under the Medicare program; SEE ADDENDUM S. 296, Preserving Access to Life-Savings Medications Act; Drug Cost Reduction Act; S. 2002 and H.R. 4095, Online Pharmacy Safety Act; S. 1251, Medicare and Medicaid FAST Act; S. 882, STOP Act; S. 319, Pharmaceutical Market Access and Drug Safety Act of 2011; S. 1002, SAFE Doses Act; H.R. 4215, The Medicare Pharmacy Transparency and Fair Auditing Act; Prescription Drug User Fee Act; Pharmaceutical Supply Chain Security; Drug Shortages legislation; Prescription drug diversion and abuse; TRICARE Pharmacy Benefit/Provisions for inclusion in National Defense Authorization Act for FY2013; Medicare Part B Revalidation; Hydrocodone Issues; S. 3376, PACT Act, S. 2467 and S. 3254 and H.R. 4310, the National Defense Authorization Act for Fiscal Year 2013; S. 3604, Improving Dementia Care Treatment for Older Adults Act of 2012;
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), Office of Personnel Management (OPM), SENATE
NATIONAL COMMUNITY PHARMACISTS ASSOCIATION via NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
2012 · second_quarter · Q2
S. 1058 and H.R. 1971, the Pharmacy Competition and Consumer Choice Act of 2011; H.R. 1936, the Medicare Access to Diabetes Act of 2011; H.R. 1946, the Preserving Our Hometown Independent Pharmacies Act of 2011; S. 1560, Nursing Home Resident Pain Relief Act of 2011; S. 1699, a bill to reduce the costs of prescription drugs under the Medicare program; Sought Congressional support for the FTC investigation of the merger between two major national PBMs; SEE ADDENDUM S. 296, Preserving Access to Life-Savings Medications Act; Drug Cost Reduction Act; S. 2002 and H.R. 4095, Online Pharmacy Safety Act; S. 1251, Medicare and Medicaid FAST Act; S. 882, STOP Act; S. 319, Pharmaceutical Market Access and Drug Safety Act of 2011; S. 1002, SAFE Doses Act; H.R. 4215, The Medicare Pharmacy Transparency and Fair Auditing Act; Prescription Drug User Fee Act; Pharmaceutical Supply Chain Security; Drug Shortages legislation; Prescription drug diversion and abuse; TRICARE Pharmacy Benefit/Provisions for inclusion in National Defense Authorization Act for FY2013; Medicare Part B Revalidation; S. 3376, PACT Act, Hydrocodone issues
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), Office of Personnel Management (OPM), SENATE
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act; Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, specifically FDA funding for implementation of the Drug Quality and Security Act
Issues related to compounded pharmaceuticals for animals; S. 1200 - Fairness to Pet Owners Act 2015; H.R. 3174 - Fairness to Pet Owners Act of 2015;
H.R. 6 - 21st Century Cures Act; Senate HELP Innovation Initiative: How to Get Medical Devices, Drugs, Treatments From Discovery to the Medicine Cabinet S. 1913 - Stopping Medication Abuse and Protecting Seniors Act of 2015
S. 776 - Medication Therapy Empowerment Act of 2015; H.R. 1021 - Protecting the Management Integrity of Medicare Act of 2015; H.R. 1270 - Restoring Access to Medication Act of 2015; S. 709- Restoring Access to Medication Act of 2015; H.R. 2- Medicare Access and Chip Reauthorization Act of 2015; H.R. 793 - Ensuring Seniors Access to Local Pharmacies Act of 2015; S. 1190 -Ensuring Seniors Access to Local Pharmacies Act of 2015; S. 314 - Pharmacy and Medically Underserved Areas Enhancement Act; H.R. 592 - Pharmacy and Medically Underserved Areas Enhancement Act;
Small Business Tax Reform
TRICARE Pharmacy Benefit Provisions; National Defense Authorization Act H.R. 4909 - National Defense Authorization Act; S. 2943 - National Defense Authorization Act
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), Office of Personnel Management (OPM), SENATE
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act; Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, specifically FDA funding for implementation of the Drug Quality and Security Act
H.R. 244 - MAC Transparency Act of 2015; Congressional Oversight of 340 B Program; S. 1406 - Saving Access to Compounding Medications for Special Needs Patients Act; Direct and Indirect Remuneration fees (DIR); Issues related to FDA implementation of The Drug Quality and Security Act related to compounding
H.R. 471 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015; S. 483 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015; S.524 - Comprehensive Addiction and Recovery Act of 2016; H.R.953 - Comprehensive Addiction and Recovery Act of 2015
S. 776 - Medication Therapy Empowerment Act of 2015; H.R. 1021 - Protecting the Management Integrity of Medicare Act of 2015; H.R. 1270 - Restoring Access to Medication Act of 2015; S. 709- Restoring Access to Medication Act of 2015; H.R. 2- Medicare Access and Chip Reauthorization Act of 2015; H.R. 793 - Ensuring Seniors Access to Local Pharmacies Act of 2015; S. 1190 -Ensuring Seniors Access to Local Pharmacies Act of 2015; S. 314 - Pharmacy and Medically Underserved Areas Enhancement Act; H.R. 592 - Pharmacy and Medically Underserved Areas Enhancement Act;
H.R. 6 - 21st Century Cures Act; Senate HELP Innovation Initiative: How to Get Medical Devices, Drugs, Treatments From Discovery to the Medicine Cabinet S. 1913 - Stopping Medication Abuse and Protecting Seniors Act of 2015
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), Office of Personnel Management (OPM), SENATE
S. 776 - Medication Therapy Empowerment Act of 2015; H.R. 1021 - Protecting the Management Integrity of Medicare Act of 2015; H.R. 1270 - Restoring Access to Medication Act of 2015; S. 709- Restoring Access to Medication Act of 2015; H.R. 2- Medicare Access and Chip Reauthorization Act of 2015; H.R. 793 - Ensuring Seniors Access to Local Pharmacies Act of 2015; S. 1190 -Ensuring Seniors Access to Local Pharmacies Act of 2015; S. 314 - Pharmacy and Medically Underserved Areas Enhancement Act; H.R. 592 - Pharmacy and Medically Underserved Areas Enhancement Act;
H.R. 244 - MAC Transparency Act of 2015; Congressional Oversight of 340 B Program; S. 1200 - Fairness to Pet Owners Act 2015; H.R. 3174 - Fairness to Pet Owners Act of 2015; S. 1406 - Saving Access to Compounding Medications for Special Needs Patients Act
Small Business Tax Reform
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), Office of Personnel Management (OPM), SENATE
H.R. 793 - Ensuring Seniors Access to Local Pharmacies Act of 2015; H.R. 244 - MAC Transparency Act of 2015; Congressional Oversight of 340 B Program; S. 1200 - Fairness to Pet Act Legislation 2015; S. 1190 -Ensuring Seniors Access to Local Pharmacies Act of 2015; S. 314 - Pharmacy and Medically Underserved Areas Enhancement Act; H.R. 592 - Pharmacy and Medically Underserved Areas Enhancement Act; H.R. 3174 - Fairness to Pet Owners Act of 2015; S. 1406 - Saving Access to Compounding Medications for Special Needs Patients Act
H.R. 1735- National Dense Authorization Act for FY2016, TRICARE Pharmacy Benefit/Provisions; S. 1376 National Defense Authorization Act for FY2016, TRICARE Pharmacy Benefit/Provisions
S. 776 - Medication Therapy Empowerment Act of 2015; H.R. 1021 - Protecting the Integrity of Medicare Act of 2015; H.R. 1270 - Restoring Access to Medication Act of 2015; S. 790- Restoring Access to Medication Act of 2015; J.R. 2- Medicare Access and Chip Reauthorization Act of 2015; H.Res. 173- Providing For Consideration of the Bill (H.R. 2) to Amend Title XVII of the Social Security Act of Repeal the Medicare Sustainable Growth Rate;
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), Office of Personnel Management (OPM), SENATE
H.R. 793 - Ensuring Seniors Access to Local Pharmacies Act of 2015; H.R. 244 - MAC Transparency Act of 2015; Congressional Oversight of 340 B Program; S. 1200 - Fairness to Pet Act Legislation 2015; S. 1190 -Ensuring Seniors Access to Local Pharmacies Act of 2015; S. 314 - Pharmacy and Medically Underserved Areas Enhancement Act; H.R. 592 - Pharmacy and Medically Underserved Areas Enhancement Act;
H.R. 1735- National Dense Authorization Act for FY2016, TRICARE Pharmacy Benefit/Provisions; S. 1376 National Defense Authorization Act for FY2016, TRICARE Pharmacy Benefit/Provisions
S. 776 - Medication Therapy Empowerment Act of 2015; H.R. 1021 - Protecting the Integrity of Medicare Act of 2015; H.R. 1270 - Restoring Access to Medication Act of 2015; S. 790- Restoring Access to Medication Act of 2015; S. 810- SGR Repeal and Medicare Provider Payment Modernization Act of 2015; J.R. 2- Medicare Access and Chip Reauthorization Act of 2015; H.Res. 173- Providing For Consideration of the Bill (H.R. 2) to Amend Title XVII of the Social Security Act of Repeal the Medicare Sustainable Growth Rate; H.R. 592- Pharmacy Medically Underserved Areas Enhancement Act of 2015; S. 314- Pharmacy and Medically Underserved Area Enhancement Act of 2015
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), Office of Personnel Management (OPM), SENATE
H.R. 793 - Ensuring Seniors Access to Local Pharmacies Act of 2015; H.R. 244 - MAC Transparency Act of 2015; Congressional Oversight of 340 B Program; Fairness to Pet Act Legislation
TRICARE Pharmacy Benefit/Provisions for inclusion in the National Defense Authorization Act for FY2016;
S. 776- Medication Therapy Empowerment Act of 2015; H.R. 1021 - Protecting the Integrity of Medicare Act of 2015; H.R. 1270 - Restoring Access to Medication Act of 2015; S. 709 - Restoring Access to Medication Act of 2015; S.810 - SGR Repeal and Medicare Provider Payment Modernization Act of 2015; H.R. 2- Medicare Access and Chip Reauthorization Act of 2015; H.Res. 173 - Providing For Consideration of the Bill (H.R. 2) to Amend Title XVIII of the Social Security Act to Repeal the Medicare Sustainable Growth Rate; H.R. 592- Pharmacy and Medically Underserved Areas Enhancement Act of 2015; S. 314 - Pharmacy and Medically Underserved Areas Enhancement Act of 2015;
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), Office of Personnel Management (OPM), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), Office of Personnel Management (OPM), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE